Medtronic Launches the EnPulse Pacemaker in the United States for Simplified Management of Slow Heart Rhythms.Business Editors/Health/Medical Writers MINNEAPOLIS--(BUSINESS WIRE)--Dec. 18, 2003 Medtronic, Inc. (NYSE NYSE See: New York Stock Exchange :MDT MDT abbr. Mountain Daylight Time MDT (in the US and Canada) Mountain Daylight Time MDT n abbr (US) (= mountain daylight time) → ), the world's leading manufacturer of implantable medical devices, today announced U.S. Food and Drug Administration clearance and U.S. commercial release of the Medtronic EnPulse(TM) pacing system. The new EnPulse system incorporates an enhanced suite of features to help physicians better manage patients with slow heart rhythms and streamline the patient follow-up process, including: -- Search AV +: This automatic and expanded search method senses the patient's natural heartbeats before delivering pacing therapy, which may reduce unnecessary stimulation impulses in the ventricle ventricle /ven·tri·cle/ (ven´tri-k'l) a small cavity or chamber, as in the brain or heart.ventric´ular ventricle of Arantius the rhomboid fossa, especially its lower end. , the heart's lower chamber. Recent clinical studies have suggested that reducing this pacing stimulation may reduce the patient's risk of developing heart failure. In addition, by reducing these impulses, the longevity of the device may be extended. -- Quick Look II screen: This new, innovative data display allows clinicians to instantly access complete information about the patient's heart rhythm and pacemaker activity on a single, easy-to-understand screen, which simplifies the device follow-up process and may allow physicians to spend more quality time with the patient instead of performing lengthy pacemaker tests. In addition, new trend monitoring capabilities may reduce the amount of time needed to gather key information and shorten patient office visits. -- Ventricular Response Pacing (VRP VRP Vehicle Routing Problem VRP Voyageur, Représentant, Placier (French) VRP Vehicle Recycling Partnership (USA) VRP Versatile Routing Platform VRP Vanuatu Republican Party VRP Vessel Response Plans ): Some patients who have episodes of atrial fibrillation atrial fibrillation Irregular rhythm (arrhythmia) of contraction of the atria (upper heart chambers). The most common major arrhythmia, it may result as a consequence of increased fibrous tissue in the aging heart, of heart disease, or in association with severe infection. - a fast, disorganized dis·or·gan·ize tr.v. dis·or·gan·ized, dis·or·gan·iz·ing, dis·or·gan·iz·es To destroy the organization, systematic arrangement, or unity of. heart rhythm originating in the heart's upper chambers - also experience uneven heart contractions in the ventricles Ventricles The two chambers of the heart that are involved in pumping blood. The right ventricle pumps blood into the lungs to receive oxygen. The left ventricle pumps blood into the circulation of the body to deliver oxygen to all of the body's organs and tissues. , which can cause palpitations and discomfort for the patient. VRP is a specialized form of pacing that may help the ventricles contract with a regular rhythm. "The new EnPulse device brings together several important features that will help deliver excellent therapy for patients and simplify their device checks," said Steven Compton, M.D., an electrophysiologist at Alaska Heart Institute in Anchorage. "Physicians will appreciate the existing combination of offerings, as well as the ability to easily add new therapies to this device in the future through software upgrades." The EnPulse dual-chamber devices can be upgraded with new therapies, allowing for forthcoming enhancements that in the future could be enabled without patient surgery through a programmer software upgrade. "The EnPulse device now takes its place as the premier system in Medtronic's new pacing product line, and the offering of this new combination of device features demonstrates our continued commitment to provide effective treatment options for the 250,000 patients who receive pacemakers each year," said Steve Mahle, president, Medtronic Cardiac Rhythm Management Cardiac rhythm management is a field of treatment in cardiology. The purpose is managing cardiac rhythm disorders. Usually it involves artificial pacemakers and/or implantable cardioverter-defibrillator therapy as well as antiarrhythmia drugs. . Medtronic, Inc., headquartered in Minneapolis, is the world's leading medical technology company, providing lifelong solutions for people with chronic disease. Its Internet address There are two kinds of addresses that are widely used on the Internet. One is a person's e-mail address, and the other is the address of a Web site, which is known as a URL. Following is an explanation of Internet e-mail addresses only. For more on URLs, see URL and Internet domain name. is www.medtronic.com. Any statements made about the company's anticipated financial results and regulatory approvals are forward-looking statements subject to risks and uncertainties such as those described in Medtronic's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended April 25, 2003. Actual results may differ materially from anticipated results. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion